One of the major agents of infectious tracheobronchitis in dogs is canine parainfluinza virus (CPiV) which is known to cause acute-onset and highly transmissible cough. This study was aimed at determining the prevalence of CPI infection in dogs referred to the Veterinary Clinic of Shiraz University in 2013-2014. Nasal and tracheal swabs were taken from 30 apparently healthy dogs without respiratory signs and 50 sick dogs with clinical respiratory signs. Full set of characteristics including age, sex, breed, contact with other dogs, place of keeping, respiratory and general symptoms were recorded. The molecular detection of canine parainfluenza virus by semi nested reverse transcriptase PCR were performed and further confirmed by nucleotide sequencing of the last products. The results showed that the occurrence of CPiV infection in healthy dogs was 13.33% whereas it was 20% in dogs with respiratory signs. The sequencing and nucleotide blast showed no variation among determined sequences. The occurrence was higher in non-vaccinated and outdoor dogs. This study is the first attempt to detect CPiV infection in Fars province, Iran and the data obtained may be useful for outbreak preventions and to raise awareness of potential transmission of the disease to the small animals in the area.
INTRODUCTION
Canine infectious respiratory complex disease (CIRDC), previously called canine infectious tracheobronchitis (or kennel cough) is a highly contagious disease that is caused by the viral agents including canine adenoviruses, canine parainfluenza virus, canine respiratory coronavirus and the bacteria such as Bordetella bronchiseptica, Mycoplasma spp. and Streptococcus zooepidemicus. The agents are transmitted by air from infected dogs, especially in poorly ventilated kennels, animal shelters, and veterinary hospitals (Ellis & Krakowka, 2012; Ford, 2012) .
One of the most common viruses believed to play a role in canine respiratory disease is canine parainfluenza virus (CPiV). The virus belongs to the family Paramyxoviridae, and is an enveloped RNA virus. The virus replicates in epithelial cells of the upper respiratory tract, and often causes no signs or mild respiratory illness. Respiratory disease may be more severe when co-infections with other pathogens such as Bordetella bronchiseptica are present. The incubation period is usually 3-10 days and the virus is shed for up to 10 days after infection (Ford, 2012; Sykes, 2014) .
Tissue culture inoculation (viral isolation) is not commonly performed. Polymerase chain reaction techniques to detect viruses from dogs with acute respiratory disease have been most useful for identification of pathogens. Suitable specimens for respiratory virus isolation or detection are nasal and pharyngeal swab specimens (Ford, 2012; Sykes, 2014) .
In Iran, there has been no molecular research for detection of prevalence of the parainfluenza virus in dogs. Therefore, the objective of the study reported here was to determine the prevalence of parainfluenza virus infections in dogs with and without respiratory signs referred to the Veterinary Teaching Clinic at Shiraz University and evaluation of infection with some epidemiological characteristics.
MATERIALS AND METHODS

Study subjects
Nasal and tracheal swabs were obtained from 50 dogs with clinical respiratory signs (sneezing and/or coughing and/or nasal and ocular discharge) (group A) and 30 healthy dogs (group B) in the Veterinary Clinic of Shiraz University in 2013 and 2014. The swabswere kept in 10 mL microtubes at -70 o C. The full set of characteristics including age, sex, breed, contact with other dogs, place of keeping (outdoor or indoor), respiratory and general symptoms was recorded.
RNA extraction protocol
Initially the swabs were soaked in 300 μL of sterile PBS and 200 μl of this was subjected to RNA isolation using Cinnagen RNA extraction kit (CinnaGen Co., Iran) according to the manufacturer instruction. Briefly, 1 mL of RNX solution was used as the lysis buffer and 200 μL of chloroform was added. The aqueous phase resulted from centrifugation was transferred to a new tube and RNA was precipitated with equal volume of isopropanol. After washing two times, total RNA was eluted in 50 μL of DNase/ RNase free water.
PCR protocol
The Complementary DNAs were synthesised using AccuPower R RT Premix, Bioneer, Korea. Briefly, 5 μL of RNA, 10 pmol of forward primer (Table 1 ) and 14 μL of DEPC water were transferred to the kit test tube, and then incubated at 42 o C for 1 h and 95˚C for 5 minutes. Semi nested PCR was performed in a total volume of 25 μL containing PCR buffer, MgCl 2 (1.5 mM), dNTPs mix (0.1 mM), the forward primer CPiV-F363 (20 pmol) for the first round (Table 1) Seven final PCR products were sequenced and analysed with blast programme of NCBI gene bank.
Statistical analysis
The relationship between infection and some risk factors was statistically analysed with Fisher test and the P values calculated.
RESULTS
The PCR products and nucleotide sequence of the last PCR product (188 bp) are shown in Fig The prevalence of parainfluenza virus infection in dogs with (group A) and Although there was no significant correlation between sex and CPiV infection but vaccination, keeping status (indoor or outdoor) and relationship with other dogs had significant correlation with the infection in the animals of both groups. In addition, a statistical relation was found between age and infection in the animals of group B.
DISCUSSION
Although infection and disease associated with CPiV have long been recognised as an important cause of canine ITB and have been most prevalent in situations where multiple-source dogs are crowded, there has been no molecular research on the prevalence and epidemiological data in Fars province, Iran. In the present study, for the first time in Iran, molecular research was performed for detection and prevalence of the parainfluenza virus in dogs. Knowledge of the prevalence of CPiV in dogs in the Shiraz area is important, because this infection is highly contagious and there are many stray and rural dogs that are not vaccinated. These animals are of concern with regard to transmission of disease to other dogs (Ford, 2012) . The reported results confirm that prevalence of CPiV infection in dogs is different, not only between countries but also between different areas of each country (Ford, 2012) .
Present study indicated that this virus is present in the ecosystem. Besides, the occurrence of CPiV infection was found in 17.5% (14/80) of dogs tested, 13.33 % in healthy dogs and 20% in dogs with respiratory signs. Erles et al. (2004) investigated viruses associated with canine infectious respiratory disease in England by PCR and found that 19.4% of tracheal and 10.4% of lung samples were positive for CPiV. Mochizuki et al. (2008) found CPiV in 7.4% of 68 household dogs showing clinical signs of respiratory infection and it was the most common etiologic agent of canine ITB in Japan. In a seroepidemiological survey of 302 healthy pet dogs in Sweden in 2003, CPiV had a seroprevalence of 28%. The dogs' ages, gender or breed did not correlate with the seroprevalence (Engelund et al., 2003) . In Mexico in 2004, CPiV was identified in 28 of 35 (51%) cases of dogs that died from acute or subacute pneumonia (Damián et al., 2005) . In another survey, a fourfold or greater rise in the titre of antibodies against canine parainfluenza virus in 79 percent of the cases revealed the etiological importance of this virus in an outbreak in Norway (Ueland, 1990) . Mosallanejad et al. (2009) found that the prevalence of canine parainfluenza virus antigens is 5.3% (4 of 76) by means of immunochromatography in Ahvaz city, Iran. Like the present study, no significant difference was found between different sexes. Besides, in the mentioned researches a more significant prevalence was observed in dogs that were in open environment compared with closed environment (Mosallanejad et al., 2009) . In the present research, outdoor dogs showed significantly more positive samples (in both groups) in comparison to indoor dogs (P<0.03). Furthermore, keeping a dog with other dog(s) is likely to pose a significant risk for increased infection. Similarly, in many researches, the crowding of dogs together has been significantly associated with the seroprevalence of CPiV and affected dogs have been more likely to have a history of recent stays in a pet shop, boarding facility, kennel or shelters (Englund et al., 2003 , Sykes, 2014 . The present study emphasises that the prevalence of CPiV is higher in kennel or open populations (P<0.03). The virus is highly contagious and efficiently transmitted from infected dogs through oronasal contact with aerosolised respiratory secretions. Among dogs housed in high density populations, transmission most likely occurs after direct contact with infected dogs or contact with aerosolised microdroplets, either from infected dogs or through freshly contaminated dishware, human hands, and other fomites (Ford, 2012; Sykes, 2014) .
Although some research found no relation between age and infection (Mosallanejad et al., 2009) , it is reported that young puppies less than 6 months of age are at increased risk (Ford, 2012) . In our study, more positive samples were detected in young dogs (under 1 year old) compared to other dogs (> 1 year old) (significantly in group B, P<0.04). It could be attributed to susceptibility of young dogs to infectious viruses because of no previous contact and immature immune system. Similar to this study, Erles et al. (2004) detected CPiV RNA in tracheal samples from dogs with all grades of CIRD as well as in samples from dogs without clinical symptoms and there was no association between the presence of CPIV and the severity of respiratory symptoms. In present study no significant differences were seen between the total prevalence of CPiV in the two populations (respiratory signs and no signs). There is a possibility that apparently healthy dog had an early stage of CIRD at which clinical signs would not yet have been manifested. Besides, the presence of other infectious respiratory agents (viruses or bacteria) could contribute to severity of disease and their detection was not included in this research.
The present results indicated that the infection was significantly more common in the dogs without history of vaccination (P<0.01). Therefore we propose proper vaccination for the protection of dogs against respiratory signs of infection with CPiV. Two of the vaccinated dogs (7.14%) in group A were detected as infected. Due to low risk of mutation of CPiV and sequencing data of detected virus (from positive dogs), with appropriate cold chain of vaccines, it seems that immunity derived from vaccination might not confer complete protection against infection. It has been proven that despite the implementation of vaccination programs against the principal pathogens associated with CIRD, outbreaks continue to be reported throughout the world (Ford, 2012; Sykes, 2014) . Parenteral and intranasal vaccines exist for CPiV. Although few studies have compared the efficacy of parenteral and intranasal vaccines, intranasal vaccination creates a more effective and more rapid (protects within 72 hours) protection than parenterally administered vaccines (Kontor et al., 1981) . Use of intranasal CPiV vaccines, as opposed to parenteral vaccines, has been suggested because they produce local immunity, reduce shedding, and can be used in puppies as young as 3 to 4 weeks of age (Welborn et al., 2011) . Unfortunately, the intranasal vaccine is not available in Iran. It seems logical for this vaccine to be provided and used in dogs, especially before keeping them with other dogs (like in kennels).
In conclusion, the results of this study indicate that CPiV is a common disease in dogs of Shiraz, and young, unvaccinated outdoor dogs or dogs that are kept with other dogs are at greater risk for infection. Further studies are required to fully control CPiV transmission and prevalence.
